Come up with a name for your new list and we'll add to it:
Sentient Bioscience raised a round of funding on September 22, 2009. Investors include
Slater Technology Fund.
Sentient Bioscience makes technology in the field of embolization therapy, a system that limits blood supply to tumors without resorting to surgery. The tumor-blocking material also delivers targeted …